Live Breaking News & Updates on Pasithea Therapeutics Corp

Stay updated with breaking news from Pasithea therapeutics corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pasithea Therapeutics Corp. Announces FDA Acceptance of Ind Application to Evaluate Pas-004 in Advanced Cancer Patients

Pasithea Therapeutics Corp. Announces FDA Acceptance of Ind Application to Evaluate Pas-004 in Advanced Cancer Patients
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Pasithea Therapeutics Corp , Us Federal Drug Administration , Pasithea Therapeutics , Investigational New Drug Application , Drug Administration , Third Quarter ,

Baystreet.ca - Pasithea Jumps as FDA Grants IND Status to Cancer Treatment

Pasithea Therapeutics Corp. (NASDAQ: KTTA) shares rise sharply first thing Tuesday. The San Francisco-based biotechnology company, focused on the discovery, research, and development of innovative treatments for Central Nervous System (CNS) disorders, . ....

United States , Tiago Reis Marques , Us Federal Drug Administration , Pasithea Therapeutics Corp , Pasithea Therapeutics , San Francisco Based , Central Nervous System , Investigational New Drug Application , Drug Administration , Reis Marques , Eastern Europe ,

Pasithea Therapeutics Stock to Reverse Split on Tuesday, January 2nd (NASDAQ:KTTA)

Pasithea Therapeutics Corp. (NASDAQ:KTTA – Free Report)’s stock is going to reverse split on Tuesday, January 2nd. The 1-20 reverse split was announced on Tuesday, January 2nd. The number of shares owned by shareholders will be adjusted after the closing bell on Tuesday, January 2nd. Pasithea Therapeutics Trading Down 5.1 % NASDAQ:KTTA traded down $0.02 […] ....

Pasithea Therapeutics Corp , Vanguard Group Inc , Securities Exchange Commission , Pasithea Therapeutics , Free Report , Therapeutics Trading Down , Get Free Report , Therapeutics Corp , Central Nervous System , Pasithea Therapeutics Daily , Nasdaq Ktta , Stock Split ,

Pasithea Therapeutics (NASDAQ:KTTA) Shares Scheduled to Reverse Split on Tuesday, January 2nd

Pasithea Therapeutics Corp. (NASDAQ:KTTA – Free Report)’s stock is going to reverse split before the market opens on Tuesday, January 2nd. The 1-20 reverse split was announced on Tuesday, January 2nd. The number of shares owned by shareholders will be adjusted after the market closes on Tuesday, January 2nd. Pasithea Therapeutics Price Performance Shares of […] ....

Exchange Commission , Pasithea Therapeutics Corp , Pasithea Therapeutics Company Profile , Vanguard Group Inc , Pasithea Therapeutics , Free Report , Get Free Report , Therapeutics Corp , Central Nervous System , Pasithea Therapeutics Daily , Nasdaq Ktta , Stock Split ,